118 related articles for article (PubMed ID: 9842962)
1. Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8-10/CD44v10 competitive RT-PCR.
Miyake H; Okamoto I; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S; Saya H
Int J Cancer; 1998 Dec; 79(6):560-4. PubMed ID: 9842962
[TBL] [Abstract][Full Text] [Related]
2. Utility of Competitive Reverse Transcription-Polymerase Chain Reaction Analysis of Specific CD44 Variant RNA for Detecting Upper Urinary Tract Transitional-Cell Carcinoma.
Miyake H; Hara I; Arakawa S; Kamidono S
Mol Urol; 1999; 3(4):365-370. PubMed ID: 10851297
[TBL] [Abstract][Full Text] [Related]
3. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
[TBL] [Abstract][Full Text] [Related]
4. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
[TBL] [Abstract][Full Text] [Related]
5. Detection of malignant cells in pleural fluid or ascites by CD44v8-10/CD44v10 competitive RT-PCR.
Ahn MJ; Noh YH; Yoon HJ; Yang SC; Sohn JW; Choi JH; Lee YY; Choi IY; Kim IS; Lee YS; Park CK
Korean J Intern Med; 2001 Mar; 16(1):30-5. PubMed ID: 11417302
[TBL] [Abstract][Full Text] [Related]
6. [Expression of CD44 variant isoform in urine samples of urothelial cancer patient].
Hara I; Miyake H; Gohji K; Arakawa S; Kamidono S
Hinyokika Kiyo; 1999 Aug; 45(8):589-92. PubMed ID: 10500968
[TBL] [Abstract][Full Text] [Related]
7. Urinary cytology and competitive reverse transcriptase-polymerase chain reaction analysis of a specific CD44 variant to detect and monitor bladder cancer.
Miyake H; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S
J Urol; 1998 Dec; 160(6 Pt 1):2004-8. PubMed ID: 9817310
[TBL] [Abstract][Full Text] [Related]
8. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.
Miyake H; Hara I; Kamidono S; Eto H
J Urol; 2004 Sep; 172(3):1127-9. PubMed ID: 15311055
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 adhesion molecules in nonpapillary renal cell carcinoma and normal kidneys.
Hara I; Miyake H; Yamanaka K; Hara S; Arakawa S; Kamidono S
Urology; 1999 Sep; 54(3):562-6. PubMed ID: 10475374
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas.
Sasaki JI; Tanabe KK; Takahashi K; Okamoto I; Fujimoto H; Matsumoto M; Suga M; Ando M; Saya H
Int J Oncol; 1998 Mar; 12(3):525-33. PubMed ID: 9472088
[TBL] [Abstract][Full Text] [Related]
11. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
[TBL] [Abstract][Full Text] [Related]
12. Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.
Hagiwara M; Kikuchi E; Tanaka N; Kosaka T; Mikami S; Saya H; Oya M
BMC Cancer; 2018 Jan; 18(1):113. PubMed ID: 29385995
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 splice variants in human skin and epidermal tumours.
Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
[TBL] [Abstract][Full Text] [Related]
14. Histiocytoid breast carcinoma: solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant.
Fujiwara M; Horiguchi M; Mori S; Yokoyama K; Horiguchi H; Fukazawa M; Fujiwara H; Yano Y; Satoh H; Kamma H
Pathol Int; 2005 Jun; 55(6):353-9. PubMed ID: 15943793
[TBL] [Abstract][Full Text] [Related]
15. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
16. The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development.
Boman BM; Viswanathan V; Facey COB; Fields JZ; Stave JW
Cancer Biol Ther; 2023 Dec; 24(1):2195363. PubMed ID: 37005380
[TBL] [Abstract][Full Text] [Related]
17. Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer.
Yamaguchi A; Zhang M; Goi T; Fujita T; Niimoto S; Katayama K; Hirose K
Oncol Rep; 2000; 7(3):541-4. PubMed ID: 10767365
[TBL] [Abstract][Full Text] [Related]
18. Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.
Inoue T; Nakanishi H; Inada K; Hioki T; Tatematsu M; Sugimura Y
J Urol; 2001 Dec; 166(6):2134-41. PubMed ID: 11696722
[TBL] [Abstract][Full Text] [Related]
19. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
Zhang P; Feng S; Liu G; Wang H; Fu A; Zhu H; Ren Q; Wang B; Xu X; Bai H; Dong C
Oncogene; 2016 Sep; 35(38):5056-5069. PubMed ID: 27041584
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
